Clustering affordable care act qualified health plans to understand how and where insurance facilitates or impedes access to HIV prevention
- PMID: 39563344
- PMCID: PMC11575131
- DOI: 10.1186/s12981-024-00674-9
Clustering affordable care act qualified health plans to understand how and where insurance facilitates or impedes access to HIV prevention
Abstract
Background: With access to and uptake of pre-exposure prophylaxis (PrEP), the United States can prevent new HIV infections. To end the HIV epidemic, health insurance plans must facilitate access to comprehensive preventive care benefits. Since plan benefit designs vary considerably by plan, it is difficult to systematically determine plans that facilitate and restrict preventive services for PrEP.
Methods: We applied an unsupervised machine learning method to cluster 17,061 Qualified Health Plans offered to individuals. We examined the clusters to draw conclusions about the types of benefits insurance companies tend to group together in plans. Then we analyzed the geographic distribution of those clusters across the United States to assess geographic inequities in access to HIV preventive care.
Results: Our method uncovered three cohesive clusters of plans. Plans in Cluster 1: the least restrictive cluster, facilitate access to preventive care using copays over coinsurance on almost all benefits; Cluster 2: the moderately restrictive cluster, plans cover HIV prevention benefits with copays but restrict access to general health benefits with coinsurance; and Cluster 3: the most restrictive cluster, plans cover almost all benefits using coinsurance. Overall, increased prior authorization requirements tend to accompany reductions in out-of-pocket costs. Examining the geographic plan distribution, states with at least one rating area where at least 75% of plans offered are in the most restrictive cluster included: Georgia, Illinois, Missouri, Oklahoma, Texas, Virginia, and Wyoming.
Conclusions: Insurance plan design is complex. To address the ambitious call to end the HIV epidemic in this country, plans should also take into account both public health and health equity factors to create plan designs that ensure access to critical preventive services for people who need them most. Addressing the growing disparities in PrEP access along racial and ethnic lines should be a national priority, and federal and state insurance regulators as well as insurance plans themselves should be part of the conversation about how to ensure people who would benefit from PrEP can access it. Better state/federal regulation of plan design to ensure access is consistent, equitable, and based on clinical recommendations will reduce the variability across plan designs.
Keywords: HIV; HIV prevention; Health insurance; Insurance benefits, cost sharing insurance; Patient protection and affordable care act; Pre-exposure prophylaxis; Prior authorization.
© 2024. The Author(s).
Conflict of interest statement
Figures
Similar articles
-
Regional Disparities in Qualified Health Plans' Prior Authorization Requirements for HIV Pre-exposure Prophylaxis in the United States.JAMA Netw Open. 2020 Jun 1;3(6):e207445. doi: 10.1001/jamanetworkopen.2020.7445. JAMA Netw Open. 2020. PMID: 32492164 Free PMC article.
-
An early examination of access to select orphan drugs treating rare diseases in health insurance exchange plans.J Manag Care Spec Pharm. 2014 Oct;20(10):997-1004. doi: 10.18553/jmcp.2014.20.10.997. J Manag Care Spec Pharm. 2014. PMID: 25278322 Free PMC article.
-
The Affordable Care Act and the Burden of High Cost Sharing and Utilization Management Restrictions on Access to HIV Medications for People Living with HIV/AIDS.Popul Health Manag. 2016 Aug;19(4):272-8. doi: 10.1089/pop.2015.0076. Epub 2015 Nov 13. Popul Health Manag. 2016. PMID: 26565514
-
Access to PrEP and other sexual health services for cisgender women in the United States: a review of state policy and Medicaid expansion.Front Public Health. 2024 Jun 25;12:1360349. doi: 10.3389/fpubh.2024.1360349. eCollection 2024. Front Public Health. 2024. PMID: 38983260 Free PMC article. Review.
-
Plan Choice And Affordability In The Individual And Small-Group Markets: Policy And Performance-Past And Present.Health Aff (Millwood). 2019 Apr;38(4):675-683. doi: 10.1377/hlthaff.2018.05401. Health Aff (Millwood). 2019. PMID: 30933593 Review.
References
-
- Centers for Disease Control and Prevention. HIV Prevention in the United States: Mobilizing to End the Epidemic. October 1, 2021. Accessed July 6. 2023. https://www.cdc.gov/hiv/pdf/policies/cdc-hiv-prevention-bluebook.pdf
-
- Centers for Disease Control and Prevention. HIV, Surveillance Report. 2021.; 2023. Accessed January 15, 2014. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html
-
- Centers for Disease Control and Prevention. Effectiveness of Prevention Strategies to Reduce the Risk of Acquiring or Transmitting HIV. HIV Risk and Prevention. June 17, 2022. Accessed July 6. 2023. https://www.cdc.gov/hiv/risk/estimates/preventionstrategies.html
-
- U.S. Food and Drug Administration. FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic. October 2019. Accessed December 13, 2019. https://www.fda.gov/news-events/press-announcements/fda-approves-second-...
-
- U.S. Food and Drug Administration. FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention. December 2021. Accessed May 1. 2023. https://www.fda.gov/news-events/press-announcements/fda-approves-first-i...
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous